← Back to Patent Explorer
US4489096A Expired / Lapsed US ⏱️ 0.0 years remaining

Quinone compounds, their production and use

Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1983-07-05
•
Granted: 1984-12-18
•
Expires: 2003-07-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New quinone compounds of the formula: ##STR1## wherein R is methyl or methoxy and Y is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or di- alkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms or carbamoyloxymethyl, or their hydroquinone-form compounds, or pharmaceutically acceptable salts thereof, have useful physiological activities such as antiasthmatic and antiallergic activities.

Inventors

  • 👤 Shinji Terao
  • 👤 Yoshitaka Maki

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 11:16
CPC Classifications
C; C07; C07D; C07D309/00; C07D309/02; C07D309/08; C07D309/10; C07D309/12; A; A61; A61P; A61P3/00; A61P3/06; C07C; C07C46/00; C07C50/00; C07C50/38; C07C66/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 51 words
A compound of the formula: ##STR12## wherein R is methyl or methoxy and Y is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or dialkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms, or carbamoyloxymethyl, or its hydroquinone-form compound, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 51 words
A compound of the formula: ##STR12## wherein R is methyl or methoxy and Y is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or dialkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms, or carbamoyloxymethyl, or its hydroquinone-form compound, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 15 words
A compound as claimed in claim 1, wherein the compound is in the quinone form.
Claim 4
Dependent Claim 11 words
A compound as claimed in claim 1, wherein Y is carboxyl.
Claim 5
Dependent Claim 11 words
A compound as claimed in claim 1, wherein Y is carbamoyloxymethyl.
Claim 6
Dependent Claim 12 words
A compound as claimed in claim 1, wherein the compound is 2,3,5-trimethyl-6-(11-carboxyundeca-5,10-diynyl)-1,4-benzoquinone.
Claim 7
Dependent Claim 12 words
A compound as claimed in claim 1, wherein the compound is 2,3-dimethoxy-5-methyl-6-(11-carboxyundeca-5,10-diynyl)-1,4-benzoquinone.
Claim 8
Dependent Claim 12 words
A compound as claimed in claim 1, wherein the compound is 2-(12-carbamoyloxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone.
Claim 9
Dependent Claim 12 words
A compound as claimed in claim 1, wherein the compound is 2-(12-carbamoyloxydodeca-5,10-diynyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone.
Claim 10
Dependent Claim 81 words
A pharmaceutical composition suitable for suppressing the generation and release of SRS-A, which comprises as an active ingredient, an effective amount of a compound of the formula: ##STR13## wherein R is methyl or methoxy and Y is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or dialkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms, or carbamoyloxymethyl, or its hydroquinone-form compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient therefor.
Claim 11
Dependent Claim 81 words
A pharmaceutical composition suitable for suppressing the generation and release of SRS-A, which comprises as an active ingredient, an effective amount of a compound of the formula: ##STR13## wherein R is methyl or methoxy and Y is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or dialkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms, or carbamoyloxymethyl, or its hydroquinone-form compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient therefor.

References Cited (Backward Citations)

US3346595A Cited
US3957836A Cited
US4199531A Cited
US4393075A Cited
US4393075B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-12-18 1988-06-18 1988-12-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-12-18 1992-06-18 1992-12-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-12-18 1996-06-18 1996-12-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag